Virus News and Research

Latest Virus News and Research

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

A recent article published in Science Translational Medicine demonstrated that mucosally delivered adenovirus type 5 (Ad5)-based COVID-19 vaccination minimized COVID-19 transmission and severity.

9 May 2022

Diagnostic performance of monocyte distribution width and other leukocyte parameters for SARS-CoV-2 and influenza infection

Researchers used a novel diagnostic screen, monocyte distribution width for SARS-CoV-2 and influenza infection.

9 May 2022

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Researchers have been investigating the role of fomites in SARS-CoV-2 transmission.

9 May 2022

Evidence of croup associated with SARS-CoV-2

A new study published in the Journal of Pediatric Infectious Diseases Society aimed to characterize the clinical features of SARS-CoV-2-associated croup among children presenting to the ED during the phase when Omicron variant transmission was high.

9 May 2022

Benefit from convalescent plasma shown in COVID outpatient trial

Researchers have conducted a double-blind, multicentre, randomized, controlled trial, which is known as Convalescent Plasma to Limit SARS-CoV-2 Associated Complications Study to evaluate if early COVID-19 plasma treatment could reduce disease progression and, thereby, reduce hospitalization rate.

9 May 2022

COVID-19 mortality among elderly may be due to genetically predetermined limit on the immune system

Your immune system's ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease.

9 May 2022

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

A new study published in the New England Journal of Medicine has discussed the efficacy and safety profile of the ZF2001 vaccine in adults, based on a randomized, placebo-controlled, multinational, double-blind phase 3 trial.

9 May 2022

Approximately 13% of hospitalized COVID patients have serious neurologic symptoms

In a recent study in the journal Critical Care Explorations, the Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry was used to record significant neurologic signs of SARS-CoV-2 infection, as well as prehospital risk factors and outcomes.

9 May 2022

Infection with SARS-CoV-2 results in antibodies against common colds

A study published in the journal Science Advances uses electron microscopy-based polyclonal epitope mapping (EMPEM) methodology to elucidate the spike epitopes of β-HCoV targeted by preexisting serum antibodies and compares them to the epitopes targeted by antibodies elicited by SARS-CoV-2 infection using electron microscopy-based polyclonal epitope mapping (EMPEM) methodology.

8 May 2022

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).

6 May 2022

Pathogenicity and transmissibility of SARS-CoV-2-related pangolin coronavirus

Researchers observed that pangolin coronaviruses related to SARS-CoV-2 share similar pathogenicity and transmissibility in hamsters.

6 May 2022

Study reveals why some lungs are protected against COVID

COVID-19 vaccines have saved at least a million lives in the United States alone, but for many people, a lingering fear remains: if - or when - they get hit by the coronavirus, just how bad will it be? Will they breeze through with little more than a sore throat - or will it saddle them with long-term complications, perhaps even push them to the brink of death?

6 May 2022

Potential antiviral targets in SARS-CoV-2

Researchers assessed potential targets in severe acute respiratory syndrome coronavirus 2.

6 May 2022

Scientists explore immunopathology of COVID-19

Researchers explored the interactions between severe acute respiratory syndrome coronavirus 2 and the host in the development of COVID-19.

6 May 2022

A guide to help you keep up with the omicron subvariants

Two years into the coronavirus pandemic, Americans can be forgiven if they've lost track of the latest variants circulating nationally and around the world. We've heard of the alpha, beta, gamma, delta, and omicron variants, but a new Greek-letter variant hasn't come onto the scene in almost half a year.

6 May 2022

Marine bioactive compounds against SARS-CoV-2

A new review paper published in the journal Environmental Science and Pollution Research aimed to determine the possibilities of using biologically active compounds derived from various chemical classes of marine organisms against SARS-CoV-2 infection at various stages of the life cycle of the virus.

6 May 2022

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants did not evolve further to escape from T cell-mediated immunity.

6 May 2022

Variolation - Face masks might reduce COVID-19 severity

In a recent study published in the Journal of the Royal Society Interface, researchers developed an epidemiological model to demonstrate that mask-induced variolation causes milder severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 May 2022

miRNAs associated with varying clinical presentations of SARS-CoV-2

A recent article published in the journal iSCIENCE demonstrated different micro ribonucleic acids (miRNAs) linked with various presentations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

5 May 2022

Understanding the long-term impact of pandemic on Alzheimer’s research trials and people with dementia

COVID-19 and the global pandemic have caused significant disruption to all aspects of life including Alzheimer’s clinical research worldwide.

5 May 2022

Virus News and Research

Latest Virus News and Research

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

Diagnostic performance of monocyte distribution width and other leukocyte parameters for SARS-CoV-2 and influenza infection

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Evidence of croup associated with SARS-CoV-2

Benefit from convalescent plasma shown in COVID outpatient trial

COVID-19 mortality among elderly may be due to genetically predetermined limit on the immune system

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

Approximately 13% of hospitalized COVID patients have serious neurologic symptoms

Infection with SARS-CoV-2 results in antibodies against common colds

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

Pathogenicity and transmissibility of SARS-CoV-2-related pangolin coronavirus

Study reveals why some lungs are protected against COVID

Potential antiviral targets in SARS-CoV-2

Scientists explore immunopathology of COVID-19

A guide to help you keep up with the omicron subvariants

Marine bioactive compounds against SARS-CoV-2

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

Variolation - Face masks might reduce COVID-19 severity

miRNAs associated with varying clinical presentations of SARS-CoV-2

Understanding the long-term impact of pandemic on Alzheimer’s research trials and people with dementia

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in